<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001297'>Stroke</z:hpo> is the third leading cause of <z:hpo ids='HP_0011420'>death</z:hpo> and disability around the globe </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of the present investigation was to evaluate the protective effect of <z:chebi fb="0" ids="28775">hesperidin</z:chebi> and its nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> mechanism against <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> reperfusion injury </plain></SENT>
<SENT sid="2" pm="."><plain>Bilateral common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> for 30 min followed by 24 h reperfusion was given to induce <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in rats </plain></SENT>
<SENT sid="3" pm="."><plain>Animals were pretreated with <z:chebi fb="0" ids="28775">hesperidin</z:chebi> (50 and 100 mg/kg, po) for 7 days </plain></SENT>
<SENT sid="4" pm="."><plain>Various behavioural tests, <z:mp ids='MP_0003674'>oxidative stress</z:mp> parameters, endogenous <z:chebi fb="11" ids="22586">antioxidant</z:chebi> system, <z:chebi fb="11" ids="22586">antioxidant</z:chebi> enzyme activity and <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> enzyme complex (I, II, III and IV) dysfunctions in cortex and striatum were assessed subsequently </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="28775">Hesperidin</z:chebi> (50 and 100 mg/kg) significantly improved neurobehavioral alterations (neurological score, locomotor activity, resistance to lateral push and hanging wire latency), attenuated oxidative damage, restored <z:chebi fb="11" ids="22586">antioxidant</z:chebi> and <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> complex enzyme activities in cortex and in striatum regions of the brain as compared to their respective controls </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> (100 mg/kg) or L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e> (10 mg/kg) pretreatment with lower dose of <z:chebi fb="0" ids="28775">hesperidin</z:chebi> (50 mg/kg) significantly reversed or potentiated its protective effect, respectively which was significant as compared to <z:chebi fb="0" ids="28775">hesperidin</z:chebi> (50 mg/kg) </plain></SENT>
<SENT sid="7" pm="."><plain>The results highlight the involvement of nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> mechanism in the protective effect of <z:chebi fb="0" ids="28775">hesperidin</z:chebi> against <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> reperfusion injury induced alterations </plain></SENT>
</text></document>